65 million reasons why this is stock should be on your radar

	Stock of the Week In case you missed last week's action on TSXV:NUMI, OTC:LKYSF, Today we're putting it right back at the top of our radar! Last week saw TSXV:NUMI, OTC:LKYSF close a C$40 million ... Unsubscribe Advertisement Stock of the Week In case you missed last week's action on TSXV:NUMI, OTC:LKYSF, Today we're putting it right back at the top of our radar! Last week saw TSXV:NUMI, OTC:LKYSF close a C$40 million bought deal. Numinus now has $65-million on hand and is well capitalized to act on revenue-generating growth initiatives including the Numinus Bioscience lab expansion, clinic acquisitions and purpose-built flagship facilities. Now armed with a warchest of cash ahead of its clinical trials, this company could be making some serious moves in the near future. It's not often that we come across a company that could make a serious impact on the World! But TSXV:NUMI, OTC:LKYSF appears to be one of those situations! With the COVID-19 Virus still raging across the globe, new strains emerging, and lockdowns still in place, TSXV:NUMI, OTC:LKYSF is easily among the most consequential plays we have ever profiled. WHY? Because Mental health care is broken! And TSXV:NUMI, OTC:LKYSF is a company that can FIX IT! We'll delve more into that, but if this is the first time you're hearing about TSXV:NUMI, OTC:LKYSF and their remarkable potential, read our report right here ...
This message is a paid advertisement for Numinus Wellness Inc. (TSXV:NUMI) from Summit Publishing Group and Stock Street News. American Consumer News, LLC dba MarketBeat receives a fixed fee for each subscriber that clicks on a link in this email, totaling up to $15,000. Other than the compensation received for this advertisement sent to subscribers, MarketBeat and its principles are not affiliated with either Summit Publishing Group or Stock Street News. MarketBeat and its principles do not own any of the stocks mentioned in this email or in the article that this email links to. Neither MarketBeat nor its principles are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from MarketBeat to buy or sell any security. MarketBeat has not evaluated the accuracy of any claims made in this advertisement. MarketBeat recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding Numinus Wellness Inc. (TSXV:NUMI) on Stock Street News' website for additional information about the relationship between Stock Street News and Numinus Wellness Inc. (TSXV:NUMI). If you would no longer like to receive promotional emails from MarketBeat advertisers, you can unsubscribe or manage your mailing preferences here. © 2006-2021 American Consumer News, LLC dba MarketBeat. 326 E 8th St #105, Sioux Falls, SD 57103. United States.